GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Translation dysregulation in neurodegeneration

$707,634
Daniela C Zarnescu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · NS

Autoimmunity Center of Excellence (ACE) at Stanford

$707,559
Charles Garrison Fathman · Stanford University · U19 · FY2009 · AI

Glia maturation factor-gamma modulation of signaling pathways in macrophages

$707,429
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

Unraveling the superficial white matter of the primate brain: Tracer-based histology and dMRI tractography validation

$707,424
Richard J Rushmore · Boston University Medical Campus · R01 · FY2022 · NS

programmed cell death in regulation of autoimmunity

$707,372
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR

Deuterium metabolic imaging (DMI) of neurological disease

$706,821
Robin A De Graaf · Yale University · R01 · FY2019 · EB

Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals

$706,519
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2025 · MH

Cannabinoid regulation of cognition

$706,390
Michael A Taffe · Scripps Research Institute, The · R01 · FY2015 · DA

Extensive multiplexing of protein nucleic-acid interactions to comprehensively study gene expression regulation from chromatin to mRNA degradation

$706,299
Marko Jovanovic · Columbia Univ New York Morningside · R01 · FY2024 · HG

Receptor Mediated T and B Cell Activation

$706,073
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study

$705,882
James Graham Wilson · University Of Mississippi Med Ctr · R01 · FY2009 · HL

The enteric microbiome in treated and progressive HIV infection

$705,157
Douglas Kwon · Massachusetts General Hospital · R01 · FY2015 · DK

Molecular mechanisms relating Poldip2 to endothelial permeability

$705,011
Kathy K Griendling · Emory University · R01 · FY2024 · HL

Brain predictors of mobility and falls in older adults with multiple sclerosis

$704,983
Roee Holtzer · Albert Einstein College Of Medicine · R01 · FY2019 · NS

Nuclear receptors: action, functions, and roles in disease

$704,937
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES

The role of the AR interactome in SBMA

$704,752
Diane E Merry · Thomas Jefferson University · R37 · FY2024 · NS

Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection

$704,526
Mahesh Mohan · Texas Biomedical Research Institute · R01 · FY2021 · DA

Electroporation-Mediated Gene Therapy with IFN-b for MS

$703,880
Ichor Medical Systems, Inc. · R44 · FY2005 · NS

Epigenetic Changes associated with Neurodegenerative Diseases

$703,862
Shelley L Berger · University Of Pennsylvania · R01 · FY2015 · NS

Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

$702,976
Monique Evangeline Hinchcliff · Yale University · R01 · FY2019 · AR

TELEPHONE PSYCHOTHERAPY--TREATMENT OF DEPRESSION IN MS

$702,828
Northern California Institute Res &Educ · R01 · FY2001 · MH

Validation of the HD-HRQOL (Huntington disease quality of life measure)

$702,798
Noelle E. Carlozzi · University Of Michigan At Ann Arbor · R01 · FY2012 · NS

Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects

$702,706
Arthur A. Vandenbark · Virogenomics Biodevelopment, Inc. · R42 · FY2017 · AI

Oklahoma Autoimmunity Center of Excellence

$702,688
Judith A James · Oklahoma Medical Research Foundation · U19 · FY2009 · AI

Improving Outcomes Assessment in Chronic Graft versus Host Disease

$702,180
Stephanie J Lee · Fred Hutchinson Cancer Center · R01 · FY2022 · CA